Current status of transarterial chemoembolization (TACE) agents in hepatocellular carcinoma treatment
Journal of Drug Delivery Science and Technology(2022)
Abstract
Primary liver cancer is among the most common fatal solid cancers, ranking as the fourth most frequent cause of cancer-related mortality worldwide. Hepatocellular carcinoma (HCC) is the most prevalent histological type of primary liver cancers, which accounts for up to 90% of cases and is resistant to a large percentage of currently available anti-cancer drugs. Amongst various therapeutic options, transarterial chemoembolization (TACE) is an efficient option in patients with the intermediate stage of HCC. Commercially, different embolients enable clinicians to perform TACE. Embolic materials include gelatin sponge, degradable starch microspheres (DSMs) and calibrated microspheres. This article reviews commercially available materials used in the TACE procedure and evaluates their pros and cons in this regard.
MoreTranslated text
Key words
Chemoembolization,Embolization,Hepatocellular carcinoma,Microsphere,Radiopaque microsphere
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined